These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 23670345)

  • 1. OCT4 is epigenetically regulated by DNA hypomethylation of promoter and exon in primary gliomas.
    Shi J; Shi W; Ni L; Xu X; Su X; Xia L; Xu F; Chen J; Zhu J
    Oncol Rep; 2013 Jul; 30(1):201-6. PubMed ID: 23670345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OCT4 is up-regulated by DNA hypomethylation of promoter in recurrent gliomas.
    Wu Y; Sun B; Shi W; Ni L; Chen J; Cai G; Shi J
    Neoplasma; 2016; 63(3):378-84. PubMed ID: 26925786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oct4 is expressed in human gliomas and promotes colony formation in glioma cells.
    Du Z; Jia D; Liu S; Wang F; Li G; Zhang Y; Cao X; Ling EA; Hao A
    Glia; 2009 May; 57(7):724-33. PubMed ID: 18985733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oct4 is epigenetically regulated by methylation in normal placenta and gestational trophoblastic disease.
    Zhang HJ; Siu MK; Wong ES; Wong KY; Li AS; Chan KY; Ngan HY; Cheung AN
    Placenta; 2008 Jun; 29(6):549-54. PubMed ID: 18440631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative Oct4 overproduction in mouse embryonic stem cells results in prolonged mesoderm commitment during hematopoietic differentiation in vitro.
    Camara-Clayette V; Le Pesteur F; Vainchenker W; Sainteny F
    Stem Cells; 2006 Aug; 24(8):1937-45. PubMed ID: 16690781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New advances of microRNAs in glioma stem cells, with special emphasis on aberrant methylation of microRNAs.
    Zhao B; Bian EB; Li J; Li J
    J Cell Physiol; 2014 Sep; 229(9):1141-7. PubMed ID: 24374932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells.
    Xu N; Papagiannakopoulos T; Pan G; Thomson JA; Kosik KS
    Cell; 2009 May; 137(4):647-58. PubMed ID: 19409607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gradual DNA demethylation of the Oct4 promoter in cloned mouse embryos.
    Yamazaki Y; Fujita TC; Low EW; Alarcón VB; Yanagimachi R; Marikawa Y
    Mol Reprod Dev; 2006 Feb; 73(2):180-8. PubMed ID: 16245355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oct4 expression in in-vitro-produced sheep blastocysts and embryonic-stem-like cells.
    Sanna D; Sanna A; Mara L; Pilichi S; Mastinu A; Chessa F; Pani L; Dattena M
    Cell Biol Int; 2009 Dec; 34(1):53-60. PubMed ID: 19947952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
    Kar S; Patra SK
    Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoter hypermethylation-mediated inactivation of LRRC4 in gliomas.
    Zhang Z; Li D; Wu M; Xiang B; Wang L; Zhou M; Chen P; Li X; Shen S; Li G
    BMC Mol Biol; 2008 Nov; 9():99. PubMed ID: 18976507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of DNA methylation change in stem cell marker genes during differentiation of human embryonic stem cells.
    Yeo S; Jeong S; Kim J; Han JS; Han YM; Kang YK
    Biochem Biophys Res Commun; 2007 Aug; 359(3):536-42. PubMed ID: 17548060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spermatogonial stem cell self-renewal requires OCT4, a factor downregulated during retinoic acid-induced differentiation.
    Dann CT; Alvarado AL; Molyneux LA; Denard BS; Garbers DL; Porteus MH
    Stem Cells; 2008 Nov; 26(11):2928-37. PubMed ID: 18719224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NonO binds to the CpG island of oct4 promoter and functions as a transcriptional activator of oct4 gene expression.
    Park Y; Lee JM; Hwang MY; Son GH; Geum D
    Mol Cells; 2013 Jan; 35(1):61-9. PubMed ID: 23212346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manipulation of OCT4 levels in human embryonic stem cells results in induction of differential cell types.
    Rodriguez RT; Velkey JM; Lutzko C; Seerke R; Kohn DB; O'Shea KS; Firpo MT
    Exp Biol Med (Maywood); 2007 Nov; 232(10):1368-80. PubMed ID: 17959850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research.
    Liedtke S; Stephan M; Kögler G
    Biol Chem; 2008 Jul; 389(7):845-50. PubMed ID: 18627312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implication of human OCT4 transactivation domains for self-regulatory transcription.
    Lim HY; Do HJ; Lee WY; Kim DK; Seo HG; Chung HJ; Park JK; Chang WK; Kim JH; Kim JH
    Biochem Biophys Res Commun; 2009 Jul; 385(2):148-53. PubMed ID: 19445899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An Oct4-pRb axis, controlled by MiR-335, integrates stem cell self-renewal and cell cycle control.
    Schoeftner S; Scarola M; Comisso E; Schneider C; Benetti R
    Stem Cells; 2013 Apr; 31(4):717-28. PubMed ID: 23307555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic control of CTCFL/BORIS and OCT4 expression in urogenital malignancies.
    Hoffmann MJ; Müller M; Engers R; Schulz WA
    Biochem Pharmacol; 2006 Nov; 72(11):1577-88. PubMed ID: 16854382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNAs control de novo DNA methylation through regulation of transcriptional repressors in mouse embryonic stem cells.
    Sinkkonen L; Hugenschmidt T; Berninger P; Gaidatzis D; Mohn F; Artus-Revel CG; Zavolan M; Svoboda P; Filipowicz W
    Nat Struct Mol Biol; 2008 Mar; 15(3):259-67. PubMed ID: 18311153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.